Evolution of Prime Editing: Enhancing Efficiency and Expanding Capacity

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Genetic mutations are responsible for approximately 80% of rare human diseases, underscoring the need for advanced genome editing tools.
• The evolution of genome editing technologies, from CRISPR-Cas9 to base editors and prime editing (PE), has rapidly advanced since 2012.
• Prime editing (PE) enables precise DNA modifications, including insertions, deletions, and point mutations, without requiring double-strand breaks, showing promise for clinical applications.

Purpose of the Study:

• To review current advancements in prime editing (PE) technology.
• To highlight ongoing research focused on improving PE efficiency and expanding its capabilities.
• To discuss future directions for PE tool development in genome editing.

Main Methods:

• Review of scientific literature on prime editing (PE) technology.
• Analysis of research efforts to enhance PE efficiency and versatility.
• Exploration of strategies to overcome PE limitations for clinical applications.

Main Results:

• Prime editing (PE) offers enhanced precision and versatility for genome editing compared to earlier technologies.
• Current research is actively addressing limitations such as low editing efficiency and restricted large-scale manipulation capacity in PE.
• Significant progress has been made in developing improved PE systems and expanding their functional scope.

Conclusions:

• Prime editing (PE) is a powerful and versatile genome editing tool with significant potential for treating rare genetic diseases.
• Continued innovation is crucial to overcome existing limitations and fully realize the clinical utility of PE.
• Future research will focus on optimizing PE efficiency, broadening its editing capacity, and ensuring its safety and efficacy for therapeutic applications.